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Introduction {#sec003}
============

*Pseudomonas aeruginosa* is a gram-negative bacterium associated with the lung disease cystic fibrosis (CF) \[[@pone.0198909.ref005]\]. CF is an autosomal recessive disease caused by a defect in the cystic fibrosis transmembrane conductance regulator gene (*CFTR*) \[[@pone.0198909.ref006]\]. CFTR is a chloride ion channel that reduces the mucus volume of the epithelial lining fluid leading to dehydration and mucociliary dysfunction \[[@pone.0198909.ref007], [@pone.0198909.ref008]\]. The stagnation of mucus contributes to accumulation of bacteria, including *Pseudomonas aeruginosa*. Consequently, a sustained inflammatory response results in a gradual decline in lung function ultimately causing death for CF patients \[[@pone.0198909.ref009], [@pone.0198909.ref010]\].

Microscopical examinations indicate that *P. aeruginosa* resides in microcolonies, also known as biofilms, surrounded by numerous polymorphonuclear leukocytes (PMN) in the endobronchial mucus in lungs from CF patients with chronic lung infection \[[@pone.0198909.ref011]\]. *In vivo* measurements have revealed intense depletion of oxygen (O~2~) in the endobronchial mucus in CF patients with chronic lung infection \[[@pone.0198909.ref012]\]. The extreme depletion of O~2~ is reproduced in newly expectorated endobronchial secretions as steep oxyclines \[[@pone.0198909.ref013], [@pone.0198909.ref014]\] and is predominately caused by O~2~ consumption for production of reactive O~2~ and nitrogen species by the PMNs \[[@pone.0198909.ref015]--[@pone.0198909.ref017]\]. Consequently, O~2~ consumption by aerobic respiration is very small and anaerobic bacterial respiration is favoured in the O~2~ depleted parts of endobronchial secretions from CF patients \[[@pone.0198909.ref013], [@pone.0198909.ref018]\]. The ability of the O~2~ consumption by the accumulated PMNs to restrict *P. aeruginosa* is further evidenced by the inhibition of aerobic growth of *P. aeruginosa* by the PMNs in the endobronchial mucus in CF lungs \[[@pone.0198909.ref019]\].

Studies suggest that O~2~ limitation in the adhered biofilm resulting in low metabolic activity is correlated with high survival rates of *P. aeruginosa*'s during antibiotic treatment \[[@pone.0198909.ref020]\]. The biofilms in CF lungs are, however, not adhered to solid surfaces, but are embedded as small aggregates in the viscous endobronchial mucus \[[@pone.0198909.ref021]\]. To mimic the organisation of *P. aeruginosa* in small aggregates surrounded by viscous mucus we have embedded *P. aeruginosa* in agarose allowing us to confirm that the killing of *P. aeruginosa* biofilm by ciprofloxacin is oxygen dependent and to demonstrate that hyperbaric oxygen treatment (HBOT) increases the killing of *P. aeruginosa* by ciprofloxacin \[[@pone.0198909.ref004]\]. To further approach the situation in the infected CF lungs we mimicked the PMN-mediated low availability of oxygen for aerobic bacterial respiration by culturing the biofilms embedded in agarose for three days before assessing the effect of HBOT on the killing of *P. aeruginosa* during treatment with ciprofloxacin \[[@pone.0198909.ref003]\]. In this way we could demonstrate that when aerobic respiration was enabled by reoxygenation during HBOT, *P. aeruginosa* became susceptible to ciprofloxacin, thus confirming the contribution of bacterial respiration to increased bacterial killing by antibiotics \[[@pone.0198909.ref022]\]. *P. aeruginosa* is known to have five terminal oxidases in the electron transport chain which directly consume oxygen by reduction \[[@pone.0198909.ref023]\]. Although less efficient, *P. aeruginosa* is also capable of anaerobic respiration with N-oxides as terminal electron acceptors, leaving its overall metabolism complex \[[@pone.0198909.ref024], [@pone.0198909.ref025]\].

CF patients are treated with a wide range of antibiotics \[[@pone.0198909.ref026], [@pone.0198909.ref027]\]. The killing effect of some antibiotics, e. g. fluoroquinolones, aminoglycosides, and beta-lactams is enhanced under aerobic conditions due to formation of reactive oxygen species (ROS) \[[@pone.0198909.ref004], [@pone.0198909.ref028]\], hence oxygen availability and aerobic respiration are relevant for treatment. Two antibiotics used to treat *P. aeruginosa* biofilm infections in CF are tobramycin and ciprofloxacin \[[@pone.0198909.ref026]\]. Tobramycin has shown a considerable time delay for the penetration into biofilms which probably increases the adaptive response in the bacteria \[[@pone.0198909.ref029]\]. Several simulation studies of the bacterial killing of *P. aeruginosa* with and without adaptation have been carried out with various antibiotics, including ciprofloxacin, illuminating their pharmacokinetic and dynamic properties on *P. aeruginosa* infection and how time kill-curves evolve during treatment \[[@pone.0198909.ref030]--[@pone.0198909.ref032]\]. However, none have yet linked the observed increased killing from HBOT to an antibiotic adaptation model.

This paper investigates the dynamics of O~2~ treatment and the resulting O~2~ concentration profiles in a biofilm model of *P. aeruginosa*. The model parameters are determined in respirometry experiments and from the O~2~ penetration and unloading dynamics reported by Kolpen *et al.* \[[@pone.0198909.ref003]\] and shown in [Fig 1](#pone.0198909.g001){ref-type="fig"}. Using the oxygen model in combination with a modified version of an existing antibiotic model with ciprofloxacin treatment by Jacobs *et al.* (2016) \[[@pone.0198909.ref001]\] and Gregoire *et al.* (2010) \[[@pone.0198909.ref030]\], the dynamics of bacterial killing in a biofilm is investigated and the limitations of this and existing models are discussed.

![Oxygen profiles sampled after 90 minutes of HBOT.\
Oxygen profiles are recorded after 90 minutes of HBOT applied to a 5 mm thick agarose biofilm, hence an unloading process of an already oxygen penetrated biofilm is observed. Oxygen profiling was initiated 4 minutes after the 90 minutes HBOT and every profile takes approximately 3 minutes to record. Horizontal black bars represent supernatant and biofilm surfaces, respectively. The concentration of oxygen in the supernatant immediately after treatment is approximately 1000 *μ*M as the chamber has to be decompressed to 1 atm. The biofilm is present for depth 0 mm to 5 mm while the supernatant is present in the region from −5 mm to 0 mm. The supernatant is displayed primarily to verify that the mixing is strong in this region. Figure modified from \[[@pone.0198909.ref003]\].](pone.0198909.g001){#pone.0198909.g001}

Materials and methods {#sec004}
=====================

Bacterial strain and growth media {#sec005}
---------------------------------

The standard laboratory *P. aeruginosa* strain PAO1 was obtained from Stover *et al.* \[[@pone.0198909.ref033]\]. Growth was established in Lysogeny broth (LB) \[5 g/L yeast extract (Oxoid, Basingstoke, UK), 10 g/L tryptone (Oxoid) and 10g/L NaCl (Merck, Rahway, NJ), pH 7.5\], incubated overnight at 37°C and shaken at 150 rpm. Overnight cultures were used in micro-respirometry experiments to estimate O~2~ consumption in stationary cultures. For O~2~ consumption experiments in exponential cultures, the overnight culture was diluted in LB to OD~600~ = 0.01 and grown until OD~600~ = 0.4. Bacterial CFU counts were determined on solid lactose agar plates ('Blue plates' based on a modified Conradi--Drigalski medium containing 10 g/L detergent, 1 g/L Na~2~S~2~O~3~ ⋅ H~2~O, 0.1 g/L bromothymolblue, 9 g/L lactose and 0.4 g/L glucose, pH 8.0; Statens Serum Institut, Copenhagen, Denmark) to select for Gram-negative bacteria. All plates were incubated overnight at 37°C.

Oxygen depletion measurements {#sec006}
-----------------------------

For bulk O~2~ depletion experiments in planktonic cultures respiration vials (OXVIAL4) with integrated stripes of the O~2~ sensitive REDFLASH-indicators glued to the inner wall (Pyro-Science, GmbH) were positioned on top of a magnetic stirring head connected to a magnetic stirrer (Model 300, Rank Brothers, Cambridge, UK). The O~2~ concentration measurements were recorded with separately available adaptor rings (ADVIAL4, Pyro-Science) to allow easy fixation of bare optical fibers (SPFIB-BARE, Pyro-Science) which connect the respiration vials to an optical oxygen meter (FireStingO~2~, FSO2-4, Pyro Science). The software Pure Oxygen Logger (v.3.206 with FireStingO~2~ (Firmware 3.07), Pyro-Science) measured O2 in continuous mode with sampling every 1 s. The used channels were activated; the respective sensor code, output unit, as well as environmental conditions for the sample temperature (\[°C\]), pressure (\[mbar\]), and salinity (\[g/L\]) were entered. The temperature was fixed at 37°C and the pressure was fixed at 1013 mbar. The factory calibration was used to calibrate the sensors (OXVIAL4) according to the manufacturer's recommendation. O~2~ concentrations were measured in both stationary and exponential cultures diluted 10 times in LB.

For vertical space-time profiles in biofilms we used the data reported by Kolpen *et al.* \[[@pone.0198909.ref003]\]. For completeness, we provide brief experimental details for these data: PAO1 biofilms were grown and treated under anoxic conditions in an anaerobic growth chamber. The optical density at 600 nm (OD~600~) of overnight cultures of PAO1 was adjusted to 0.4 before 100-fold dilution in LB medium supplemented with 2% 2-hydroxyethyl-agarose (Sigma-Aldrich, Brøndby, Denmark) and 1 mL was loaded into 24-well microtiter plates to achieve a cell loading of ∼10^6^ cells/ml. The biofilm size was 5.7 mm high and 15 mm wide. The medium was supplemented with anoxic NaNO~3~ (1 mM) to enable anaerobic respiration. The supernatant was replaced daily with 1 mL of LB medium supplemented with 1 mM NaNO3. Microtiter plates were covered with Parafilm and lid and were incubated under anoxic conditions at 37°C for 3 days. The 3 day old biofilm was treated for 90 min with HBOT (100% O~2~ at 2.8 bar). Less than 1 minute after ending the treatment, the microtiter plate was positioned on a heated metal rack and kept at 37°C. The vertical O~2~ profiles were recorded with a fiber-optic O~2~ microsensor positioned with a micromanipulator (50 *μ*m tip diameter, FireSting2, Profix version 4.51; Pyro-Science GmbH, Germany). The microsensor was calibrated according to the manufacturer's recommendations (air saturated and O~2~-free water). The microsensor was positioned at the base of the biofilm sample and profiles were recorded while moving the sensor in vertical steps of 100 *μ*m through the biofilm sample.

Analysis {#sec007}
========

Overview of Analysis: First we model the oxygen consumption in a well mixed culture as described in "Reaction model". This serves to determine the basic parameters needed to describe the oxygen consumption. Next, in "Reaction-diffusion model for oxygen", we combine the obtained oxygen consumption model with a simple diffusion model. This allows us to verify that the hyperbaric oxygen penetration into a biofilm model reported by \[[@pone.0198909.ref003]\] and shown in [Fig 1](#pone.0198909.g001){ref-type="fig"} are qualitatively described. Finally, in "Ciprofloxacin model with oxygen consumption", a full model describing the killing by ciprofloxacin in combination with hyperbaric oxygen treatment is constructed. This model includes a mechanism for reversible adaptive oxygen-dependent killing. This enables us to give predictions for the combined effect of HBOT and ciprofloxacin treatment.

Reaction model {#sec008}
--------------

A simple reaction model using a Michaelis-Menten reaction term is presented in [Eq (1)](#pone.0198909.e001){ref-type="disp-formula"} where *c* is the molar concentration of oxygen. The model includes two parameters, namely *K*~*m*~ and *R*~max~. The latter is the maximum consumption rate and has in other studies \[[@pone.0198909.ref034]--[@pone.0198909.ref037]\] been decomposed into a subset of parameters as seen in [Eq (2)](#pone.0198909.e002){ref-type="disp-formula"}, where *μ*~max~ is the maximum specific growth rate with units of h^−1^, *ε*~*c*~ is the dimensionless volume fraction occupied by cells, *ρ*~*x*~ is the intrinsic cellular oxidase density with units *μ*M, and *Y*~*x*,*o*~ is the dimensionless oxygen yield coefficient. Importantly, [Eq (1)](#pone.0198909.e001){ref-type="disp-formula"} reveals that the overall consumption in a biofilm scales linearly in the volume fraction occupied by cells. $$\begin{array}{r}
{\frac{dc}{dt} = - R_{\text{max}}\frac{c}{K_{m} + c}} \\
\end{array}$$ $$\begin{array}{r}
{R_{\text{max}} = \frac{\mu_{\text{max}}\,\varepsilon_{c}\,\rho_{x}}{Y_{x,o}}} \\
\end{array}$$ The parameter *K*~*m*~ acts as a cut-off value, indicating the oxygen concentration below which limitation sets in. Even though PA has five terminal oxidases which reduce oxygen \[[@pone.0198909.ref024]\], we shall describe the process using just one value for *K*~*m*~. This works well, since the individual cutoffs all lie within an order of magnitude from *K*~*m*~ = 4 *μ*M \[[@pone.0198909.ref023]\]. Our maximal oxygen reaction velocity therefore represents the sum of contributions from all oxidases.

The solution to [Eq (1)](#pone.0198909.e001){ref-type="disp-formula"} is obtained by integration as presented in [Eq (3)](#pone.0198909.e003){ref-type="disp-formula"} where *c*(0) is the initial concentration of oxygen. $$\begin{array}{r}
{c\left( t \right) = K_{m}\,\text{W}\!\left( \frac{c\left( 0 \right)}{K_{m}}\mspace{600mu}\exp\left( \mspace{600mu}\frac{c\left( 0 \right) - R_{\text{max}}\, t}{K_{m}}\mspace{600mu} \right)\mspace{600mu} \right)} \\
\end{array}$$ The solution involves the Lambert W function, which is the inverse of *x* → *x*e^*x*^ \[[@pone.0198909.ref038]\]. Estimates of *R*~max~ and *K*~*m*~ may now be established by fitting the experimental data as illustrated in [Fig 2](#pone.0198909.g002){ref-type="fig"}. Experimental data is obtained from respirometry experiments as described in Materials and Methods.

![Oxygen consumption for overnight cultures of PAO1.\
Dots represent experimental data and the red lines are the solution from [Eq (3)](#pone.0198909.e003){ref-type="disp-formula"} with respective parameters.](pone.0198909.g002){#pone.0198909.g002}

In [Fig 2](#pone.0198909.g002){ref-type="fig"}, three typical respirometry profiles and fits with [Eq (3)](#pone.0198909.e003){ref-type="disp-formula"} are shown. Using the solution from [Eq (3)](#pone.0198909.e003){ref-type="disp-formula"}, the value of *K*~*m*~ was determined from a total of 14 respirometry experiments shown in [S1](#pone.0198909.s001){ref-type="supplementary-material"}--[S4](#pone.0198909.s004){ref-type="supplementary-material"} Figs. The parameter values providing the best fit were computed using the Levenberg-Marquardt algorithm in MATLAB with an integer weighting to compensate for the statistical underrepresentation of data in the tail.

The average *K*~*m*~ for the first batch of experiments with six similar cultures is 3.4 *μ*M (see [S1](#pone.0198909.s001){ref-type="supplementary-material"} and [S2](#pone.0198909.s002){ref-type="supplementary-material"} Figs). In [Fig 2](#pone.0198909.g002){ref-type="fig"}, three of these are shown. Additionally, another batch of eight respirometry experiments were conducted where an average *K*~*m*~ of 0.62 *μ*M was observed (see [S3](#pone.0198909.s003){ref-type="supplementary-material"} and [S4](#pone.0198909.s004){ref-type="supplementary-material"} Figs). Clearly, *K*~*m*~ is very low and the bacteria can thus easily be saturated with oxygen. The variation in *K*~*m*~ probably arises from the interactivity of the five terminal oxidases present in *P. aeruginosa* \[[@pone.0198909.ref039]\]. A study by Arai *et al.* \[[@pone.0198909.ref023]\] determined *K*~*m*~ for each oxidase to be between 0.23-4.3 *μ*M corresponding well to the respirometry results.

The estimate of *R*~max~ in [Fig 2](#pone.0198909.g002){ref-type="fig"} is centered around 1.5 attomol per second per bacteria but some variation of this parameter was seen across the 14 different profiles. The mean value of *R*~max~ was calculated to be $2.57\,\frac{\text{amol}}{\text{s} \cdot \text{bac}}$ and ranges from a minimum value of $1.22\,\frac{\text{amol}}{\text{s} \cdot \text{bac}}$ to a maximum value of $5.70\mspace{720mu}\frac{\text{amol}}{\text{s} \cdot \text{bac}}$. Interestingly, it was observed that the cultures that exhibited exponential growth had an average *R*~max~ value of $4.48\mspace{720mu}\frac{\text{amol}}{\text{s} \cdot \text{bac}}$ which would indicate a shift in consumption rate per bacteria when entering a stationary phase. However, the number of profiles of exponentially growing cultures was low (*n* = 3) and further respirometry experiments are therefore required to confirm this.

Reaction-diffusion model for oxygen {#sec009}
-----------------------------------

As a first attempt to understand the effect of HBOT in biofilm, oxygen profiles were sampled immediately after HBOT by Kolpen *et al.* (2017) in \[[@pone.0198909.ref003]\] as reproduced in [Fig 1](#pone.0198909.g001){ref-type="fig"}. In the experiment, a series of oxygen profiles were sampled after 90 minutes of HBOT as the oxygen level returned to normoxic. By modelling the oxygen profiles one should be able to predict the condition of the biofilm during treatment. Assuming that the underlying oxygen consumption mechanism is similar to that in the planktonic cells in the respirometry experiments, the data can be described by adding a diffusion term to the rhs of [Eq (1)](#pone.0198909.e001){ref-type="disp-formula"}. We then get a 1-dimensional reaction-diffusion equation as seen in [Eq (4)](#pone.0198909.e008){ref-type="disp-formula"}. $$\begin{array}{r}
{\frac{\partial c}{\partial t} = D_{\text{O}_{2}}\frac{\partial^{2}c}{\partial z^{2}} - R_{\text{max}}\frac{c}{K_{m} + c}} \\
\end{array}$$

When the concentration of oxygen is large, *c* ≫ *K*~*m*~, the penetration depth of oxygen scales in proportion to the square root of the oxygen concentration at the boundary.

When the oxygen concentration is below *K*~*m*~, the reaction-diffusion equation is reduced to: $$\begin{array}{r}
{\frac{\partial c}{\partial t} = D_{\text{O}_{2}}\frac{\partial^{2}c}{\partial z^{2}} - \frac{R_{\text{max}}}{K_{m}}c} \\
\end{array}$$ with the steady state solution $$\begin{array}{r}
{c\left( z \right) = c_{0}\mspace{600mu}\text{e}^{- \lambda_{z}z}} \\
\end{array}$$ for thick biofilms.

The first-order assumption gives the relationships between *K*~*m*~ and *R*~max~: $$\begin{array}{rcl}
{R_{\text{max}} = K_{m}D_{\text{O}_{2}}\lambda_{z}^{2}} & & {\lambda_{t} = D_{\text{O}_{2}}\lambda_{z}^{2}} \\
\end{array}$$

These relationships make it possible to estimate *R*~max~. Although estimates of this parameter were already made in the previous analysis of the respirometry experiments, it would be appropriate to compare the maximum consumption in a biofilm culture with the planktonic cultures used in the respirometry experiments. The fit was made on the tail of the last oxygen profile in [Fig 1](#pone.0198909.g001){ref-type="fig"} such that a steady-state approximation was appropriate, and for data points below 4 *μ*M such that a first-order reaction could be assumed. The fit was done with the Levenberg-Marquardt method in MATLAB R2016b. The result of the interpolation and fit is shown in [S5 Fig](#pone.0198909.s005){ref-type="supplementary-material"}. Prior to fitting the data were smoothed using cubic spline in `interp1` in MATLAB R2016b and an offset correction was included in the fit.

The resulting estimate of *R*~max~ is 81 *μ*M/min in the upper part of the biofilm. This value was calculated by choosing a representative value for *K*~*m*~ of 3.8 *μ*M, the mean of the cutoffs obtained by Arai *et al.* (2014) \[[@pone.0198909.ref023]\] of the *bo*~3~, CIO, and *aa*~3~ enzymes, which are the ones we expect to dominate the oxygen consumption during HBOT \[[@pone.0198909.ref023]\]. As noted, the oxidase regulation of the five oxidases is quite complex \[[@pone.0198909.ref039]\] and may influence the value of *K*~*m*~.

In the experiment reported by Kolpen *et al.* \[[@pone.0198909.ref003]\], where the supernatant is replaced and contains fresh nutrient as well as NaNO~3~ during the anaerobic phase, the cell density is higher in the top of the biofilm after the three days of anaerobic growth. We may estimate the cell density from the fitted reaction velocity, *R*~max~ = 81 *μ*M/min and the consumption per bacteria, ∼3 amol/s/cell and arrive at 5 ⋅ 10^8^ CFU/mL near the surface of the biofilm. This is significantly higher than the average density in the biofilm in \[[@pone.0198909.ref003]\] which is in the order of 10^7^ CFU/mL. The elevated value is a consequence of unevenly distributed growth in the biofilm resulting from oxygen during aerobic growth and NaNO~3~ during anaerobic growth, both being supplied from the biofilm interface. Bearing in mind the uneven cell distribution in the experiment, we expect only a qualitative agreement between the model and the data.

The reaction-diffusion equation in [Eq (4)](#pone.0198909.e008){ref-type="disp-formula"} was solved with the numerical solver `pdepe` in MATLAB that uses an implementation by Skeel *et al.* \[[@pone.0198909.ref040]\]. Since the supernatant appears to be only moderately mixed we adapted a pragmatic approach where the boundary concentrations at the surface of the biofilm are controlled by a polynomial spline fitted to the experimental data. Similarly the initial concentration of oxygen in the biofilm is constructed as a polynomial spline through the first oxygen profile in [Fig 1](#pone.0198909.g001){ref-type="fig"}. The algorithm chosen to fit the parameters in [Eq (3)](#pone.0198909.e003){ref-type="disp-formula"} was the Levenberg-Marquardt algorithm in MATLAB.

Ciprofloxacin model with oxygen consumption {#sec010}
-------------------------------------------

The reaction-diffusion model provides a suitable basis for investigating the effect of oxygen when treating PAO1 biofilms with antibiotics. A generic model is presented here, containing mechanisms that introduce oxygen-induced antibiotic killing.

The geometry of such a model is seen in [Fig 3](#pone.0198909.g003){ref-type="fig"} showing one domain for introduction of antibiotics, i.e. the supernatant and another for the biofilm \[[@pone.0198909.ref003]\]. The model is intended to provide a qualitative prediction for an experiment in a microtiter plate filled with 5 mm biofilm containing agarose with 1.25 mm well mixed liquid supernatant. Ciprofloxacin and oxygen levels are controlled in the supernatant from where it diffuses into the biofilm. Reflective boundary conditions at the bottom are assumed for oxygen and ciprofloxacin.

![Geometry of ciprofloxacin model coupled with oxygen treatment.\
Sketch of the 1-dimensional model implemented in MATLAB. The origin is placed at the interface between the supernatant and the biofilm domains, hence the top of the supernatant has coordinate *z* = −1.25 mm, the top of the biofilm has *z* = 0 mm, and the bottom of the biofilm has coordinate *z* = 5 mm.](pone.0198909.g003){#pone.0198909.g003}

Adaptation of bacteria to the antibiotic can be modelled in several ways. However, model 5 from Jacobs *et al.* (2016) \[[@pone.0198909.ref001]\] fits well in this context as it contains one bacterial population with a reversible adaptation to antibiotics. In order to make the ciprofloxacin killing dependent on the growth rate, we multiply the killing term by the normalised growth rate as seen in the last term in [Eq (10)](#pone.0198909.e014){ref-type="disp-formula"}. The resulting model is displayed in Eqs ([8](#pone.0198909.e012){ref-type="disp-formula"})--([13](#pone.0198909.e017){ref-type="disp-formula"}), where *z* is the depth into the biofilm.

Inside the biofilm, i. e. for *z* \> 0, the model reads

Oxygen: $$\begin{array}{r}
{\frac{\partial c}{\partial t} = D_{\text{O}_{2}}\frac{\partial^{2}c}{\partial z^{2}} - R_{\text{max}}\frac{c}{K_{m} + c}\,\frac{\varepsilon}{\varepsilon_{\text{norm}}}} \\
\end{array}$$ Ciprofloxacin: $$\begin{array}{r}
{\frac{\partial u}{\partial t} = D_{\text{cip}}\frac{\partial^{2}u}{\partial z^{2}}} \\
\end{array}$$ Bacteria: $$\begin{array}{r}
{\frac{\partial\varepsilon}{\partial t} = \mu\left( c \right)\left( 1 - \frac{\varepsilon}{\varepsilon_{\text{max}}} \right)\varepsilon - K_{\text{max}}\mspace{600mu}\frac{\mu\left( c \right)}{\mu_{\text{max}}}\mspace{600mu}\frac{u^{\gamma}}{\textit{KC}_{50S}^{\gamma} + u^{\gamma}}\varepsilon} \\
\end{array}$$ Adaptation: $$\begin{array}{r}
{\frac{\partial\beta}{\partial t} = \left( \frac{S_{\text{max}}\mspace{720mu} u}{SC_{50} + u} - \beta \right)k_{\text{out}}} \\
\end{array}$$ Functions: $$\begin{array}{r}
{\textit{KC}_{50S} = \textit{KC}_{50,\text{base}}\mspace{720mu}\left( 1 + \beta \right)} \\
\end{array}$$ $$\begin{array}{r}
{\mu\left( c \right) = \mu_{\text{max}}\mspace{600mu}\frac{c}{K_{m} + c}} \\
\end{array}$$

[Eq (8)](#pone.0198909.e012){ref-type="disp-formula"} is the oxygen model from [Eq (4)](#pone.0198909.e008){ref-type="disp-formula"} but the reaction term is scaled to be proportional to the fraction of live bacteria in the biofilm. [Eq (9)](#pone.0198909.e013){ref-type="disp-formula"} describes the diffusion of ciprofloxacin from the supernatant into the biofilm. [Eq (10)](#pone.0198909.e014){ref-type="disp-formula"} describes the change in bacterial concentration within the biofilm and is separated into two terms describing the oxygen-dependent growth and the oxygen-dependent killing effect of ciprofloxacin, respectively. The growth term in [Eq (10)](#pone.0198909.e014){ref-type="disp-formula"} is assumed to follow a local logistic growth model with an oxygen dependent specific growth rate following Monod kinetics as shown in [Eq (13)](#pone.0198909.e017){ref-type="disp-formula"}. This is a fair assumption since the volume fraction occupied by cells is well below 1% in the studied biofilms.

The initial bacterial concentration in the biofilm is set to 5 ⋅ 10^8^ CFU/mL so the simulation captures the estimated oxygen consumption in the top of the biofilm, as observed in the experiments by Kolpen *et al.* \[[@pone.0198909.ref003], [@pone.0198909.ref004]\]. This is about an order of magnitude lower than in a fully developed biofilm. To ensure an oxygen-dependent killing, the killing term is scaled by the normalised oxygen-dependent growth (*μ*(*c*)/*μ*~max~). A similar strategy for incorporating oxygen-dependent killing was used by Stewart (1994) \[[@pone.0198909.ref034]\] in a model without adaptation. The effect of an adaptive susceptibility to antibiotics has been shown to be considerable \[[@pone.0198909.ref030], [@pone.0198909.ref032]\]. [Eq (11)](#pone.0198909.e015){ref-type="disp-formula"} includes both an up and down regulation of adaptation.

The combined oxygen and ciprofloxacin model in Eqs ([8](#pone.0198909.e012){ref-type="disp-formula"})--([13](#pone.0198909.e017){ref-type="disp-formula"}) was solved with `pdepe` using a 1-dimensional model presented in [Fig 3](#pone.0198909.g003){ref-type="fig"} assuming radial and axial symmetry. We use the estimated oxygen consumption parameters, diffusion parameters, and kinetic parameter values suggested in the literature as detailed in [Table 1](#pone.0198909.t001){ref-type="table"}. Both oxygen and ciprofloxacin are assumed to be well mixed in the supernatant domain and this was implemented in `pdepe` by setting an artificially high diffusion constant, hence it remains nearly uniformly distributed in the supernatant domain throughout the simulation. As an alternative to using a unit step function to connect the variables across the interface we use a fast shifting logistic function.

10.1371/journal.pone.0198909.t001

###### Parameter values used for simulation of the oxygen and ciprofloxacin models.

![](pone.0198909.t001){#pone.0198909.t001g}

  Parameter                                                          Symbol          Value              Reference
  ------------------------------------------------------------------ --------------- ------------------ --------------------------------------------------------------------------------
  Diffusion constant of oxygen                                       *D*~O~2~~       9.44 mm^2^/h       \[[@pone.0198909.ref041]\]
  Maximum oxygen reaction velocity                                   *R*~max~        81 *μ*M/min        CS[^a^](#t001fn001){ref-type="table-fn"}[^b^](#t001fn002){ref-type="table-fn"}
  Oxygen concentration for half-maximum reaction velocity            *K*~*m*~        3.8 *μ*M           \[[@pone.0198909.ref023]\], CS
  Diffusion constant ciprofloxacin                                   *D*~cip~        1.44mm^2^/h        \[[@pone.0198909.ref042]\]
  Maximum effect of ciprofloxacin                                    *K*~max~        8 h^−1^            \[[@pone.0198909.ref003]\], CS[^c^](#t001fn003){ref-type="table-fn"}
  Maximum specific growth rate                                       *μ*~max~        0.40 h^−1^         \[[@pone.0198909.ref037]\]
  Maximum adaptation                                                 *S*~max~        4                  \[[@pone.0198909.ref001]\]
  Initial half-maximum killing rate concentration of ciprofloxacin   *KC*~50,base~   0.2 *μ*g/mL        \[[@pone.0198909.ref002]\]
  Antibiotic concentration that yields 50% of *S*~max~               *SC*~50~        1.06 *μ*g/mL       \[[@pone.0198909.ref001]\]
  Turnover rate constant for adaptation                              *k*~*out*~      0.05 h^−1^         \[[@pone.0198909.ref001]\]
  Hill coefficient                                                   *γ*             1.2                \[[@pone.0198909.ref030]\]
  Maximum population density                                         *ε*~max~        10^9.5^ CFU/mL     \[[@pone.0198909.ref001]\]
  Normalisation constant                                             *ε*~norm~       5 ⋅ 10^8^ CFU/mL   CS

^a^ Current Study

^b^ Estimated from fit of λ~*t*~ and respirometry experiments.

^c^ Estimated from time-kill curves by Kolpen and coworkers.

The initial conditions in the biofilm are *c*~0~ = 0, *u*~0~ = 0, *ε*~0~ = 10^6^ CFU/mL, and *β*~0~ = 0, and the initial conditions in the supernatant domain are *c*~0~ = the applied oxygen concentration, *u*~0~ = the actual dose, *ε*~0~ = 0 CFU/mL, and *β*~0~ = 0. Hence, the introduction of antibiotics is implemented as a uniform initial condition in the supernatant.

Results and discussion {#sec011}
======================

Oxygen model {#sec012}
------------

Using the estimated parameters for *R*~max~ and *K*~*m*~, the reaction-diffusion equation, [Eq (4)](#pone.0198909.e008){ref-type="disp-formula"}, was simulated and compared with the experimental oxygen profiles in [Fig 1](#pone.0198909.g001){ref-type="fig"} as shown in [Fig 4](#pone.0198909.g004){ref-type="fig"}.

![Numerical solutions of the reaction-diffusion equation with a michaelis-menten reaction term.\
Dots are experimental data from [Fig 1](#pone.0198909.g001){ref-type="fig"} and the coloured lines are matching numerical solutions to [Eq (4)](#pone.0198909.e008){ref-type="disp-formula"}. The biofilm extends from depth 0 mm to 5 mm, but only the part with measurable oxygen concentration is shown in the figure.](pone.0198909.g004){#pone.0198909.g004}

Looking at [Fig 4](#pone.0198909.g004){ref-type="fig"}, the dynamics of the oxygen profiles are qualitatively described by a reaction-diffusion model with a Michaelis-Menten reaction term. As mentioned, *R*~max~ is proportional to the CFU unit count in the biofilm and is thus scaled linearly with the live cell-to-volume fraction in [Eq (2)](#pone.0198909.e002){ref-type="disp-formula"}. A more detailed model could include a reaction velocity scaled to per bacteria such that the units of *R*~max~ would be in amol⋅s^−1^ bac^−1^. Such a model would be able to describe oxygen consumption across a larger range of bacterial concentrations instead of relying on an estimate of *R*~max~ for a specific cell density as done here. In [S1](#pone.0198909.s001){ref-type="supplementary-material"} and [S2](#pone.0198909.s002){ref-type="supplementary-material"} Figs it is observed that there is a difference between zero-growth and exponential-growth PAO1 cultures. Generally, the larger *R*~max~ values suggest that exponential-growth cultures are consuming oxygen at a higher capacity per bacterium than zero-growth bacteria. However, further studies are needed to accurately estimate at which bacterial concentration the shift from exponential capacity to stationary capacity happens.

Also, *K*~*m*~ may vary between different experiments depending on their growth conditions prior to starting HBOT because of the five terminal oxidases that respond to different regulatory mechanisms as described by \[[@pone.0198909.ref039]\].

Antibiotic model {#sec013}
----------------

As mentioned, it has been thoroughly investigated by Kolpen *et al.* \[[@pone.0198909.ref003], [@pone.0198909.ref004]\] that treatment of *P. aeruginosa* with fluoroquinolones like ciprofloxacin shows a time-dependent increased killing when supplementing treatment with high concentrations of oxygen. We have proposed a pharmacodynamic biofilm model accounting for this increased killing, as seen in Eqs ([8](#pone.0198909.e012){ref-type="disp-formula"})--([13](#pone.0198909.e017){ref-type="disp-formula"}).

The simulations show an oxygen-dependent increased killing as seen in [Fig 5](#pone.0198909.g005){ref-type="fig"} where the volume averaged CFU counts are displayed. At the largest ciprofloxacin dose, we observe 2 orders of magnitude decrease in the CFU after about 2 hours of combined ciprofloxacin and HBOT treatment.

![Predicted volume-averaged time kill curves for normoxic oxygen treatment and HBOT.\
Different dosing schemes over 4 hours of treatment simulated in a 5 mm biofilm model. The initial ciprofloxacin concentrations in the 1.25 mm supernatant are displayed in the figures while the fully equilibrated concentrations are 5 times lower. Left: Normoxic treatment. Right: Hyperbaric oxygen treatment.](pone.0198909.g005){#pone.0198909.g005}

HBOT increases the penetration depth as seen in [Fig 6](#pone.0198909.g006){ref-type="fig"}. This leads to faster growth and metabolic activity, thus making the bacteria more susceptible to antibiotic treatment. However, [Fig 5](#pone.0198909.g005){ref-type="fig"} indicates that the opposing growth is still large enough to compensate the oxygen-dependent killing for initial doses below 1 *μ*g/mL (0.2 *μ*g/mL equilibrated concentration). [Fig 7](#pone.0198909.g007){ref-type="fig"} reveals the distribution of live bacteria in the biofilm: bacteria survive near the bottom and die at the top.

![Oxygen penetration.\
Simulation of oxygen penetration in a 5 mm biofilm following a 4 hour treatment scheme with six different ciprofloxacin dosings. The initial concentration ciprofloxacin in the supernatant is indicated in the figure. The equilibrated concentration is 5 times lower. Left: Normoxic treatment. Right: Hyperbaric oxygen treatment.](pone.0198909.g006){#pone.0198909.g006}

![Bacterial killing along the depth dimension of the biofilm.\
Simulation of a 4 hour treatment scheme with six different doses of ciprofloxacin in a 5 mm biofilm model. The initial concentration ciprofloxacin in the supernatant is indicated in the figure while the equilibrated concentration is 5 times lower. Bacterial density is measured in (CFU/mL). Left: Normoxic treatment. Right: Hyperbaric oxygen treatment.](pone.0198909.g007){#pone.0198909.g007}

The combined oxygen model with antibiotic killing provides a mechanism for oxygen enhanced killing. The model has a number of opposing effects such as bacterial growth, oxygen-dependent killing, antibiotic adaptation, and oxygen consumption that all contribute to the killing of bacteria. The HBOT makes the culture metabolically active deep into the biofilm. At sufficiently high concentrations of antibiotics the metabolic activity is suppressed and the oxygen is allowed to penetrate even deeper into the biofilm. This, in turn, allows killing even below the normal penetration depth for the oxygen. In this sense, the effect is self-perpetuating. Of course, the parameter values have a significant influence on the simulation and the above dynamics. In further studies it would be interesting to challenge the model against experimental data to see if our model that incorporates oxygen-dependent killing suffices in describing the already observed increased bacterial killing under oxygen treatment by \[[@pone.0198909.ref003], [@pone.0198909.ref004]\].

Conclusion {#sec014}
==========

A reaction-diffusion model with a Michaelis-Menten reaction term adequately describes *P. aeruginosa*'s oxygen consumption in an artificial PAO1 biofilm. Important model parameters, *K*~*m*~ and *R*~max~, have been determined by performing respirometry experiments and fitting data to an existing PAO1 experiment with HBOT, respectively. Furthermore, we constructed an antibiotic model that included a mechanism for adaptive oxygen-dependent killing of *P. aeruginosa* by introducing a normalised oxygen-growth rate into the antibiotic killing. The increase of the penetration depth of oxygen caused by the HBOT is further boosted by the killing effect from the antibiotics, thus causing the effect to be more efficient than would be naively expected.

In the model, oxygen limitation allows *P. aeruginosa* to survive in biofilms in a dormant state. Hyperbaric oxygen treatment induces metabolic activity and growth, thus increasing the susceptibility for antibiotics leading to a more efficient killing of bacteria. In the specific geometry studied, we find that 4 hours of combined treatment with HBOT and ciprofloxacin at initial concentration 1 *μ*g/mL, results in an equilibrated ciprofloxacin concentration of 0.2 *μ*g/mL and full penetration of oxygen. This, in turn, ensures efficient killing.

The oxygen model presented here describes the oxygen consumption in PAO1 biofilms qualitatively and it is clear that HBOT has the potential to play an important role in the treatment of *P. aeruginosa* biofilm infections with selected antibiotics.

Supporting information {#sec015}
======================

###### Fit of the last oxygen profile from [Fig 1](#pone.0198909.g001){ref-type="fig"}.

Interpolation (black dots) of last oxygen profile (blue dots) from in vitro experiment with PAO1 biofilm after HBOT by Kolpen *et al.* (2016) and subsequent fit of interpolated data (red line).

(EPS)

###### 

Click here for additional data file.

###### Oxygen consumption for exponential PAO1 culture.

Dots represent experimental data and the red line is the fit. CFU from left to right: 2.2, 2.40, and 2.80 ⋅ 10^7^ mL^−1^.

(EPS)

###### 

Click here for additional data file.

###### Oxygen consumption for stationary PAO1 culture.

Dots represent experimental data and the red line is the fit. CFU is 1.8 ⋅ 10^9^ mL^−1^ for all three.

(EPS)

###### 

Click here for additional data file.

###### Oxygen consumption for stationary PAO1 culture.

Dots represent experimental data and the red line is the fit. CFU = 1.7 ⋅ 10^8^ mL^−1^.

(EPS)

###### 

Click here for additional data file.

###### Oxygen consumption for stationary PAO1 culture.

Dots represent experimental data and the red line is the fit. CFU = 2.3 ⋅ 10^8^ mL^−1^.

(EPS)

###### 

Click here for additional data file.

###### Concentration of ciprofloxacin in the supernatant and the biofilm 2, 4, 6, and 8 hours after introduction of 4 *μ*g/mL in the supernatant.

(EPS)

###### 

Click here for additional data file.
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